News for Privia Health Group, Inc. (PRVA)

On Tuesday, Barclays analyst Andrew Mok increased the price target on Privia Health Group Inc. (NASDAQ:PRVA) to $24 from $23, while maintaining an Equal Weight rating on the shares. This revision follows Privia Health’s Q1 2025 report, which demonstrated steady progress with modest outperformance in its fee-for-service business. In Q1, Privia Health reported a 12.8% […]

On May 27, 2025, Barclays analyst Andrew Mok updated his outlook on Privia Health Gr (PRVA), maintaining an "Equal-Weight" rating on the stock. The update comes

Barclays has revised its price target for Privia Health (PRVA), increasing it slightly from $23 to $24, while maintaining an Equal Weight rating on the stock fo

The following slide deck was published by Privia Health Group, Inc.

Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsRobert Borchert - Senior Vice...

Implemented Provider Growth: 11.7% year-over-year increase.Value-Based Attribution Growth: 11.1% year-over-year increase.Practice Collections: Increased 12.8%

Privia Health Group Inc (PRVA) reports a 15.6% increase in revenue year-over-year.Operating income surged by 534.0%, showcasing significant operational efficie

May 08, 2025 / 12:00PM GMTOperator Thank you for standing by. My name is Dee, and I will be your conference operator. At this time. I would like to welcome ever

While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Privia Health (PRVA) delivered earnings and revenue surprises of -50% and 5.37%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

**media[618657]**

Get a deeper insight into the potential performance of Privia Health (PRVA) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

UnitedHealth Group (UNH) has reduced its full-year financial outlook following its first-quarter earnings report, citing adjustments due to care activity and me

In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In ...

Baird analyst Michael Ha has increased the price target for Privia Health (PRVA) to $26, up from the previous $24, while maintaining an Outperform rating on the

In a recent assessment, Truist has revised its price target for Privia Health (PRVA), lowering it from $30 to $28 while maintaining a Buy rating. This adjustmen

In anticipation of the upcoming first-quarter earnings in the managed care sector, Barclays has revised its price target for Privia Health (PRVA). The financial

On April 9, 2025, Privia Health Group Inc (PRVA) announced its strategic expansion into Arizona through a definitive agreement with Integrated Medical Services,

IMS is One of the Largest Independent Multi-Specialty Practices in the State Arizona Represents 15th State in National Primary Care-Centric Care Delivery Netwo